openPR Logo
Press release

Sickle Cell Anemia - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

02-23-2023 04:08 AM CET | Health & Medicine

Press release from: global insight services

Sickle Cell Anemia - Drug Pipeline

Sickle Cell Anemia - Drug Pipeline

As per Global Insight services' assessment, about 150+ prominent pharma and biotech giants are working on 20+ drugs in the Sickle Cell Anemia - pipeline landscape globally. Sickle Cell Anemia Pipeline Insight, 2023" report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies: https://www.globalinsightservices.com/request-sample/GIS31252

Key Players
• Afimmune Biopharma Ltd
• Agios Pharmaceuticals Inc
• Aruvant Sciences GmbH
• Ascentage Pharma Group Inc
• Astellas Pharma Inc
• Aviceda Therapeutics Inc
• Bausch Health Americas Inc
• Beam Therapeutics Inc

Report Highlights
Global Insight Service's, Sickle Cell Anemia - Drug Pipeline Landscape, 2023 report provides an overview of the Sickle Cell Anemia pipeline drugs. This report covers detailed insights on Sickle Cell Anemia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Sickle Cell Anemia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Buy Now: https://www.globalinsightservices.com/checkout/single_user/GIS31252

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sickle Cell Anemia - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here

News-ID: 2944550 • Views:

More Releases from global insight services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases


More Releases for Sickle

Growth Analysis & Projection of Sickle Cell Anemia Therapeutics Market
in sickle cell anemia, some red blood cells look like sickles used to cut wheat. These unusually shaped cells give the disease its name. Sickle cell anemia is one of a group of inherited disorders known as sickle cell disease. It affects the shape of red blood cells, which carry oxygen to all parts of the body. TheSickle Cell Anemia Therapeutics Market research report is proficient and top to bottom research
Outlook (2020-2030) Sickle Cell Market: Industry Analysis
Press Release - 12 April 2018 Global Research and Development News -- . . Report Description- '
Global Sickle Cell Anemia Drug Market : Sickle Cell Anaemia Industry Analysis, S …
Worldwide Market Reports added Latest Research Report titled "Global Sickle Cell Anemia Drug Market Professional Survey Report 2018" to its Large Report database. This report studies Sickle Cell Anemia Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with
Global Sickle Cell Disease Treatment Market: Sickle Cell Anaemia Anticipated to …
Researchmoz added Most up-to-date research on "Global Sickle Cell Disease Treatment Market: Sickle Cell Anaemia Anticipated to be the Most Lucrative Disease Type Segment Through 2025" to its huge collection of research reports. Persistence Market Research has come up with a new report titled “Sickle Cell Disease Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” for the projected period of 8-years. According to this report, weighted average selling price has
Sickle Cell Disease Drug Development Pipeline Review, 2017
"The Report Sickle Cell Disease Drug Development Pipeline Review, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Sickle Cell Disease Drug Development Market This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and vaso-occlusive crisis
Sickle Cell Disease Therapeutic Pipeline Market Review 2017
Pune, India, 7th December 2017: WiseGuyReports announced addition of new report, titled “Sickle Cell Disease Drug Development Pipeline Review, 2017”. Summary This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and vaso-occlusive crisis associated with sickle cell disease, and features dormant and discontinued projects. Sickle cell anemia is a